Stockscreener 앱 받기
10.15
5.84%
0.56
시간 외 거래:
10.19
0.04
+0.39%
전일 마감가:
$9.59
열려 있는:
$9.58
하루 거래량:
1.50M
Relative Volume:
1.35
시가총액:
$615.87M
수익:
$65,400
순이익/손실:
$-46.34M
주가수익비율:
-11.80
EPS:
-0.86
순현금흐름:
$-38.74M
1주 성능:
-21.74%
1개월 성능:
+14.04%
6개월 성능:
+73.80%
1년 성능:
+190.83%
1일 변동 폭
$9.58
$10.28
1주일 범위
$9.40
$11.94
52주 변동 폭
$2.57
$13.85
CorMedix Inc Stock (CRMD) Company Profile
명칭
CorMedix Inc
전화
908-517-9500
주소
400 Connell Drive, 5th Floor, Suite 5000, Berkeley Heights, NJ
CorMedix Inc Stock (CRMD) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2021-02-17 | 개시 | Needham | Buy |
| 2020-09-29 | 개시 | JMP Securities | Mkt Outperform |
| 2020-09-21 | 개시 | Truist | Buy |
| 2019-12-18 | 개시 | B. Riley FBR | Buy |
| 2019-03-26 | 재확인 | H.C. Wainwright | Buy |
| 2018-12-06 | 개시 | ROTH Capital | Buy |
| 2017-09-25 | 재확인 | H.C. Wainwright | Buy |
| 2017-08-10 | 재확인 | Rodman & Renshaw | Buy |
| 2017-05-05 | 재확인 | Rodman & Renshaw | Buy |
| 2016-11-11 | 재확인 | FBR & Co. | Outperform |
| 2016-03-17 | 재확인 | FBR Capital | Outperform |
| 2016-03-03 | 개시 | FBR Capital | Outperform |
| 2015-11-16 | 재확인 | ROTH Capital | Neutral |
| 2015-10-29 | 재확인 | ROTH Capital | Neutral |
| 2015-05-06 | 다운그레이드 | ROTH Capital | Buy → Neutral |
| 2014-12-08 | 재확인 | ROTH Capital | Buy |
| 2011-10-03 | 다운그레이드 | Maxim Group | Buy → Hold |
모두보기
CorMedix Inc 주식(CRMD)의 최신 뉴스
CorMedix's SWOT analysis: defencath launch boosts stock outlook - Investing.com India
CorMedix's SWOT analysis: defencath launch boosts stock outlook By Investing.com - Investing.com UK
CorMedix Inc. to Participate in the Truist Securities BioPharma Symposium - The Manila Times
Analysts Just Made A Massive Upgrade To Their CorMedix Inc. (NASDAQ:CRMD) Forecasts - Simply Wall St
Rainbows and Unicorns: CorMedix Inc. (NASDAQ:CRMD) Analysts Just Became A Lot More Optimistic - Yahoo Finance UK
While shareholders of CorMedix (NASDAQ:CRMD) are in the black over 1 year, those who bought a week ago aren't so fortunate - Yahoo Finance UK
Recent 23% pullback isn't enough to hurt long-term CorMedix (NASDAQ:CRMD) shareholders, they're still up 188% over 1 year - Simply Wall St
CorMedix Inc. (NASDAQ:CRMD) Q3 2024 Earnings Call Transcript - Insider Monkey
CorMedix (CRMD) Reports Q3 Loss, Tops Revenue Estimates - MSN
CorMedix Inc. Reports Q3 2024 Financial Results - TipRanks
CorMedix (CRMD) Q3 2024 Earnings Call Transcript - The Motley Fool
Earnings call: CorMedix Inc. reports Q3 financials, DefenCath drives growth - Investing.com
Earnings call: CorMedix Inc. reports Q3 financials, DefenCath drives growth By Investing.com - Investing.com UK
TSX Composite Index (TXCX) QuotePress Release - The Globe and Mail
CorMedix: Q3 Earnings Snapshot - Press of Atlantic City
CorMedix Inc. Reports Third Quarter and Nine Month 2024 Financial Results and Provides Business Update - The Manila Times
CorMedix earnings beat by $0.06, revenue topped estimates - Investing.com UK
CorMedix Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Stellantis N.V. (STLA-N) QuotePress Release - The Globe and Mail
Cormedix Inc (CRMD) Q3 2024 Earnings Report Preview: What To Loo - GuruFocus.com
CorMedix stock soars to 52-week high, hits $13.52 - Investing.com India
CorMedix 2.0: New Leadership, New Approval, New Focus (NASDAQ:CRMD) - Seeking Alpha
CorMedix stock soars to 52-week high, hits $13.52 By Investing.com - Investing.com UK
(CRMD) Trading Advice - Stock Traders Daily
Undercovered Dozen: CorMedix, Cabaletta, Skyx Platforms, Dynex Capital + - Seeking Alpha
Spotify Technology S.A. (SPOT-N) QuotePress Release - The Globe and Mail
CorMedix Inc. Announces New Data at ASN Kidney Week 2024 - The Manila Times
Mauritian Rupee/U.S. Dollar (MURUSD) QuotePress Release - The Globe and Mail
CorMedix Inc. to Report Third Quarter 2024 Financial Results and Provide a Corporate Update on October 30, 2024 - The Manila Times
CorMedix Inc. (CRMD): A Bull Case Theory - Insider Monkey
Teucrium Wheat (WEAT-A) QuotePress Release - The Globe and Mail
CorMedix stock soars to 52-week high, hits $11.07 By Investing.com - Investing.com Australia
CorMedix stock soars to 52-week high, hits $11.07 - Investing.com
CorMedix Stock: Delayed Approval, Low Cash, Good Prospects (NASDAQ:CRMD) - Seeking Alpha
Objective long/short (CRMD) Report - Stock Traders Daily
Views of Wall Street’s Leading Experts on CorMedix Inc - SETE News
CRMD underperforms with a -0.59 decrease in share price - US Post News
CorMedix stock soars to 52-week high, hits $10.15 By Investing.com - Investing.com Australia
CorMedix stock soars to 52-week high, hits $10.15 - Investing.com India
Cormedix stock positioned for growth as DefenCath launch gains traction in 2H24 By Investing.com - Investing.com South Africa
CorMedix Inc (CRMD) receives a Buy rating from Rodman & Renshaw - Knox Daily
Stocks of CorMedix Inc (CRMD) are poised to climb above their peers - SETE News
CorMedix Inc Inc. (CRMD) Price Performance: A Technical Analysis Perspective - The InvestChronicle
Cormedix stock positioned for growth as DefenCath launch gains traction in 2H24 - Investing.com Australia
Deeper Dive: Understanding CorMedix Inc (CRMD) Through its Various Ratios - The Dwinnex
CorMedix Stock Trends After New Commercial Agreement with Dialysis Operator: Retail Spirit Stays ‘Bullish’ - Barchart
CorMedix Inc (CRMD) Stock: The Story of a 52-Week Stock Range - The InvestChronicle
CorMedix Inc (CRMD) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.02%
0.47%
자본화:
|
볼륨(24시간):